Genocea, Auspex, NephroGenex file for IPO

Infectious disease company Genocea Biosciences Inc. (Cambridge, Mass.), rare neurology disease play Auspex Pharmaceuticals Inc. (La Jolla, Calif.) and kidney disease company NephroGenex Inc. (Research Triangle Park, N.C.) all filed

Read the full 307 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE